0001641241-26-000001.txt : 20260508 0001641241-26-000001.hdr.sgml : 20260508 20260507173611 ACCESSION NUMBER: 0001641241-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260508 DATE AS OF CHANGE: 20260507 EFFECTIVENESS DATE: 20260508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyrus Biotechnology, Inc. CENTRAL INDEX KEY: 0001641241 ORGANIZATION NAME: EIN: 471015686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-551903 FILM NUMBER: 26955087 BUSINESS ADDRESS: STREET 1: 3005 1ST AVE STREET 2: SUITE 203 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062586561 MAIL ADDRESS: STREET 1: 3005 1ST AVE STREET 2: SUITE 203 CITY: SEATTLE STATE: WA ZIP: 98121 D/A 1 primary_doc.xml X0708 D/A LIVE 0001641241 Cyrus Biotechnology, Inc. 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 2062586561 DELAWARE None None Corporation true Lucas Nivon 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Executive Officer Director Mark Benjamin 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Executive Officer Yifan Song 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Director Chad Waite 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Director Anthony Manning 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Director Ramakrishna Satyavolu 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Director Jason Smith 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Director Biotechnology Decline to Disclose 06b true 0001641241-25-000003 2025-07-01 false true true false 0 3000000 1481812 1518188 false 17 0 0 0 false Cyrus Biotechnology, Inc. Lucas Nivon Lucas Nivon Chief Executive Officer 2026-01-01